Acciones Rekah Pharmaceutical Industry Ltd. TEL AVIV STOCK EXCHANGE
Acciones
IL0010810096
Farmacéuticos
Ventas 2022 | 292 M 77,86 M 29,24 mil M 72,83 M | Ventas 2023 | 322 M 85,65 M 32,17 mil M 80,12 M | Capitalización | 169 M 44,92 M 16,87 mil M 42,02 M |
---|---|---|---|---|---|
Resultado Neto 2022 | -2 M -533 mil -200 M -498 mil | Resultado Neto 2023 | -6 M -1,6 M -600 M -1,49 M | VE / Ventas 2022 | 1,1 x |
Deuda neta 2022 | 145 M 38,72 M 14,54 mil M 36,22 M | Deuda neta 2023 | 166 M 44,32 M 16,64 mil M 41,46 M | VE / Ventas 2023 | 1,04 x |
P/E ratio 2022 |
-85,5
x | P/E ratio 2023 |
-24,2
x | Empleados | - |
Rendimiento 2022 * |
-
| Rendimiento 2023 |
-
| Flotante | 17,36 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 80 | 24/08/93 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 01/11/18 |
Director/Board Member | 78 | 24/08/93 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 15/04/15 |
Amiram Boehm
BRD | Director/Board Member | 52 | 15/04/15 |
Avraham Bigger
CHM | Chairman | 77 | 15/04/15 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-1,17 % | 24,26 mil M | |
+15,06 % | 8743,62 M | |
+1,22 % | 8212,06 M | |
-31,14 % | 6874,3 M | |
+16,30 % | 5286,18 M | |
+2,20 % | 4126,18 M | |
-9,24 % | 3791,65 M | |
-8,91 % | 3344,92 M | |
+7,27 % | 3186,75 M |